Fundz

Serapha Bio Appoints Kenneth T. Mills as Chief Executive Officer and Daphne Karydas as Chief Financial Officer

RECENTLY ACQUIREDSep 15, 2026

Position

Chief Medical Officer

Company

Serapha Bio

Weston Miller, MD
Hat YaiBiotechnologyHealth CareTherapeutics

Description

Serapha Bio, Inc. announces the appointment of Kenneth T. Mills as Chief Executive Officer and Daphne Karydas as President and Chief Financial Officer among other key executive roles

Quick answer

Serapha Bio Appoints Kenneth T. Mills as Chief Executive Officer and Daphne Karydas as Chief Financial Officer (September 15, 2026). Serapha Bio is based in Hat Yai, Songkhla Province, Thailand.

What did Serapha Bio announce on September 15, 2026?
Serapha Bio, Inc. announces the appointment of Kenneth T. Mills as Chief Executive Officer and Daphne Karydas as President and Chief Financial Officer among other key executive roles
What does Serapha Bio do?
Serapha Bio is a privately held company focused on developing treatments for genetic diseases.
Where is Serapha Bio based?
Serapha Bio is based in Hat Yai, Songkhla Province, Thailand.
Which similar companies made leadership changes around the same time?
AdvanCell (September 15, 2026), Oxford Brain Diagnostics (September 15, 2026), Vyome Holdings (September 14, 2026) and Q32 Bio (September 14, 2026) also announced leadership changes within 45 days of Serapha Bio.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Serapha Bio, and when

A new leader at Serapha Bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Serapha Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Serapha Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Serapha Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Serapha Bio

Location

Hat Yai, Songkhla Province, Thailand

About

Serapha Bio is a privately held company focused on developing treatments for genetic diseases. The company is geared towards bringing innovative therapies to market for conditions such as Alpha-1 Antitrypsin Deficiency. Serapha aims to improve life for patients suffering from these rare disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Serapha Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Serapha Bio's next move

Learn about Strategic plan

Serapha Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.